Targeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNA.
Myocarditis is the major heart disease in infants and young adults. It is very commonly caused by coxsackievirus B3 (CVB3) infection; however, no specific treatment or vaccine is available at present. RNA interference (RNAi)-based anti-viral therapy has shown potential to inhibit viral replication,...
Main Authors: | Xin Ye, Zhen Liu, Maged Gomaa Hemida, Decheng Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3115994?pdf=render |
Similar Items
-
Expression of RNA Nanoparticles Based on Bacteriophage Phi29 pRNA in Escherichia coli and Bacillus subtilis
by: Zhang, Le
Published: (2013) -
Assembly of Phi29 pRNA Nanoparticles for Gene or Drug Delivery and for Application in Nanotechnology and Nanomedicine
by: Shu, Yi
Published: (2012) -
Rational design for controlled release of Dicer-substrate siRNA harbored in phi29 pRNA-based nanoparticles
by: Daniel W. Binzel, et al.
Published: (2021-09-01) -
Thermodynamics and Kinetics of the Three-Way Junction of Phi29 Motor pRNA and its Assembly into Nanoparticles for Therapeutic Delivery to Prostate Cancer
by: Binzel, Daniel W.
Published: (2016) -
CLONING OF BACTERIOPHAGE-PHI29 GENE 15; ISOLATION, OVERPRODUCTION AND PURIFICATION OF PHI29 LYTIC ENZYME.
by: SAEDI, MOHAMMAD SAEED.
Published: (1987)